Internal Medicine, Medical Oncology · Oklahoma City, OK
NPI
1104870344
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3525 NW 56th St, Suite D100
Oklahoma City, OK, 73112
Phone (405) 942-9200
Groups this clinician bills Medicare through
Medicare paid, 2024
$398K
12,884 services
Medicare patients, 2024
983
Average age 75
Drug cost, 2024
$4.9M
3,502 prescriptions
Company payments, 2025
$896
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aleda A Toma was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 10,004 times for 80 patients. In total Aleda A Toma billed 12,884 services in 18 codes, and Medicare paid $398K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-24.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 10,004 | 80 | $0.10 | $1,001 |
| 99214 Office E&M - Established | Office | 941 | 324 | $65.17 | $61K |
| 99213 Office E&M - Established | Office | 606 | 448 | $41.42 | $25K |
| 99214 Office E&M - Established | Facility | 379 | 130 | $68.31 | $26K |
| 99213 Office E&M - Established | Facility | 198 | 156 | $38.12 | $7,548 |
| A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 144 | 102 | $132.00 | $19K |
| 78815 PET- Oncology | Office | 136 | 96 | $1,072.38 | $146K |
| 99204 Office E&M - New | Office | 105 | 105 | $92.86 | $9,750 |
| 71260 CT/CTA - Chest | Office | 73 | 55 | $53.59 | $3,912 |
| 74177 CT/CTA - Abdomen and Pelvis | Office | 68 | 54 | $146.95 | $9,993 |
| 99204 Office E&M - New | Facility | 67 | 67 | $97.40 | $6,526 |
| 71250 CT/CTA - Chest | Office | 29 | 18 | $40.35 | $1,170 |
| 78816 PET- Oncology | Office | 27 | 18 | $1,075.03 | $29K |
| 74176 CT/CTA - Abdomen and Pelvis | Office | 21 | 13 | $71.92 | $1,510 |
By year: 2022 $346K for 18,208 services; 2023 $361K for 14,654 services; 2024 $398K for 12,884 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aleda A Toma prescribed most often to Medicare patients was Anastrozole, with 632 prescriptions and refills. In total Aleda A Toma wrote 3,502 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 632 | 1,541 | 171 | $16K |
| Letrozole Generic | 235 | 477 | 56 | $6,673 |
| Potassium Chloride Generic | 225 | 347 | 60 | $3,710 |
| Ondansetron Hcl Generic | 156 | 156 | 75 | $1,478 |
| Omeprazole Generic | 117 | 204 | 34 | $1,688 |
| Levothyroxine Sodium Generic | 112 | 221 | 36 | $1,022 |
| Exemestane Generic | 108 | 236 | 27 | $11K |
| Gabapentin Generic | 76 | 100 | 19 | $966 |
| Acyclovir Generic | 74 | 100 | 22 | $822 |
| Promethazine Hcl Generic | 74 | 74 | 36 | $596 |
| Hydroxyurea Generic | 73 | 113 | Under 11 | $1,027 |
| Alendronate Sodium Generic | 67 | 145 | 15 | $601 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 67 | 111 | 16 | $2,193 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 65 | 65 | 22 | $1,657 |
| Oxycodone Hcl Generic | 53 | 53 | 19 | $1,105 |
Brand drugs: 501 claims; generic drugs: 3,001 claims; opioid claims: 243.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aleda A Toma $896 ($896 in general payments such as food, travel and fees) from 20 companies. The largest payer was Pfizer Inc. with $250.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 20 | $250 |
| Array Biopharma Inc PFE | 5 | $128 |
| Abbvie Inc. ABBV | 4 | $78.76 |
| GlaxoSmithKline, LLC. GSK | 4 | $72.65 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $34.94 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $30.34 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $29.31 |
| Daiichi Sankyo Inc. 4568.T | 1 | $28.94 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $28.19 |
| Eisai Inc. 4523.T | 1 | $24.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.